| Recruiting | cfMSC Therapy for Diabetes NCT07495956 | Shenzhen Geno-Immune Medical Institute | Phase 1 / Phase 2 |
| Recruiting | Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency NCT07385547 | Sun Pharmaceutical Industries Limited | Phase 1 |
| Recruiting | A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus NCT07340320 | Corxel Pharmaceuticals | Phase 2 |
| Recruiting | Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus NCT07282743 | Sun Pharmaceutical Industries Limited | Phase 2 |
| Recruiting | The GRoceries Aimed at Increasing Nutrition Study NCT07167004 | University of Pennsylvania | N/A |
| Not Yet Recruiting | Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a C NCT07047248 | University of Malaga | N/A |
| Not Yet Recruiting | Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type I NCT07084350 | General Hospital of Shenyang Military Region | N/A |
| Recruiting | Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabet NCT06561126 | Khyber Medical University Peshawar | N/A |
| Recruiting | Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabet NCT07350694 | HealthNet Transcultural Psychosocial Organization | N/A |
| Completed | A Clinical Trial to Evaluate the Food Effect of CKD-379 NCT06652971 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Recruiting | Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors NCT06570057 | Baqai Institute of Diabetology and Endocrinology | N/A |
| Completed | A Clinical Trial to Evaluate the Food Effect of CKD-378 NCT06386328 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Recruiting | Effects of Eccentric Training on Glycemic Control and Quality of Life in Patients With Type II Diabetes Mellit NCT06387550 | Foundation University Islamabad | N/A |
| Completed | Relative Hand Grip Strength and Functional Fitness in Diabetic Patient in Egypt NCT06645418 | Beni-Suef University | N/A |
| Withdrawn | Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension NCT04970108 | EMS | Phase 3 |
| Unknown | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 NCT05952219 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Pharmacokinetics and Safety/Tolerability of CKD-379 NCT05719155 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects NCT05544214 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Dual Task Performance and Type II Diabetes Mellitus NCT07107620 | Kahramanmaras Sutcu Imam University | — |
| Withdrawn | Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension NCT05144360 | EMS | Phase 3 |
| Completed | Pharmacokinetics and Safety/Tolerability Profile of CKD-379 NCT05452525 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 NCT05274880 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Active Not Recruiting | Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) NCT06030544 | Spanish National Research Council | Phase 2 |
| Completed | Dose Response of Eccentric Exercise on Glycemic Control in Type II Diabetes Mellitus NCT04790526 | Riphah International University | N/A |
| Recruiting | Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Stu NCT05164263 | Getz Pharma | Phase 4 |
| Completed | Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids NCT03912363 | Geisinger Clinic | N/A |
| Completed | Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus NCT04665284 | Getz Pharma | Phase 4 |
| Unknown | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg NCT03601910 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems a NCT03550378 | MedImmune LLC | Phase 2 |
| Terminated | A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM NCT03907202 | KeyBioscience AG | Phase 1 |
| Completed | Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes NCT02761018 | Mike O'Callaghan Military Hospital | N/A |
| Completed | Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan NCT03084965 | AstraZeneca | — |
| Unknown | Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I) NCT03025919 | Zhongda Hospital | — |
| Completed | Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine NCT03615755 | Hendry Irawan | N/A |
| Completed | Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management NCT02805361 | AstraZeneca | — |
| Terminated | A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus NCT02749435 | AstraZeneca | — |
| Completed | SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 NCT02592421 | The University of Texas Health Science Center at San Antonio | Phase 3 |
| Terminated | A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004) NCT02492763 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | Whey Protein Effect on Glycaemic and Appetite Responses in T2D NCT02903199 | Northumbria University | N/A |
| Completed | Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus NCT03059719 | PegBio Co., Ltd. | Phase 1 |
| Terminated | Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients NCT02274740 | Sanofi | Phase 2 |
| Completed | A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabe NCT02156349 | Hoffmann-La Roche | N/A |
| Completed | A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease NCT02446054 | Celio Technology Inc. | N/A |
| Available | Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM NCT02065674 | Fr Muller Homoeopathic Medical College | — |
| Completed | Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patien NCT02012478 | University of Pennsylvania | N/A |
| Completed | Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With St NCT01972724 | Takeda | Phase 4 |
| Completed | The Effect of Linagliptin on Mitochondrial and Endothelial Function NCT01969084 | Beth Israel Deaconess Medical Center | Phase 4 |
| Completed | A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers NCT01952535 | Hua Medicine Limited | Phase 1 |
| Completed | Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes M NCT01868646 | Materia Medica Holding | Phase 4 |
| Completed | Lipid Biomarkers for Diabetic Heart Disease NCT01752842 | Washington University School of Medicine | N/A |
| Completed | Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD NCT01785524 | Duke University | Phase 2 |
| Terminated | A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycem NCT01644201 | InovoBiologic Inc. | Phase 3 |
| Terminated | A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus NCT01514838 | Astellas Pharma Inc | Phase 3 |
| Completed | A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia NCT01523405 | AstraZeneca | — |
| Unknown | Mobile Health Technology as an Intervention for Diabetes Self-Management NCT01546844 | HealthInsight | N/A |
| Completed | The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes NCT01648244 | Walter Reed National Military Medical Center | N/A |
| Completed | Effects of Krill Oil on Endothelial Function in Patients With Type 2 Diabetes Mellitus NCT02091193 | Danbury Hospital | — |
| Completed | A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients NCT01505426 | Astellas Pharma Inc | Phase 3 |
| Unknown | Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellit NCT00737152 | American Scitech International | Phase 2 |
| Completed | Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus NCT01261494 | Genfit | Phase 2 |
| Completed | Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device. NCT01262586 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate NCT01196728 | CellMed AG, a subsidiary of BTG plc. | Phase 1 |
| Completed | Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulf NCT00995787 | AstraZeneca | Phase 1 |
| Completed | Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mell NCT01020123 | AstraZeneca | Phase 2 |
| Terminated | Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients NCT00997152 | Akros Pharma Inc. | Phase 2 |
| Completed | Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes NCT01076829 | University of California, Los Angeles | N/A |
| Completed | Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus NCT00960791 | AstraZeneca | Phase 1 |
| Completed | Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients NCT00929539 | Akros Pharma Inc. | Phase 2 |
| Completed | Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Fail NCT00894868 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy NCT00887302 | East Carolina University | — |
| Completed | Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes NCT00863954 | pico-tesla Magnetic Therapies, LLC | Phase 1 |
| Completed | Yellow Pea Fractions and Short-term Food Intake, Subjective Appetite and Glycemic Response NCT01242059 | University of Toronto | N/A |
| Completed | Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans NCT01165190 | Arizona State University | — |
| Completed | Yellow Pea Protein and Fibre and Short Term Food Intake NCT01255085 | University of Toronto | N/A |
| Completed | Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Al NCT00561171 | Speedel Pharma Ltd. | Phase 2 |
| Unknown | Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus NCT00540462 | Min-Sheng General Hospital | Phase 4 |
| Completed | Innovative Strategies For Risk Reduction Following CABG NCT00462436 | Unity Health Toronto | Phase 2 |
| Completed | Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dy NCT00344370 | Kowa Research Europe | Phase 3 |
| Completed | Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipid NCT00309751 | Kowa Research Europe | Phase 3 |
| Completed | Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus NCT00306176 | Aristotle University Of Thessaloniki | Phase 4 |
| Completed | A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014 NCT00481663 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study NCT00309712 | Intermountain Health Care, Inc. | N/A |
| Completed | Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease NCT00282360 | IRCCS San Raffaele | Phase 4 |